This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hale, D. E. Articles by Leach, R. J. Search for Related Content PubMed PubMed Citation Articles by Hale, D. E. Articles by Leach, R. J.

The Spectrum of Growth Abnormalities in Children with 18q Deletions¹

Departments of Pediatrics and Cellular and Structural Biology, University of Texas Health Science Center, San Antonio, Texas 78229

Address all correspondence and requests for reprints to: Daniel E. Hale, M.D., Department of Pediatrics, University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, Texas 78229. E-mail: hale{at}uthscsa.edu

The objective of this study was to assess the spectrum of growth abnormalities in children with 18q deletions. The growth axis of 50 individuals with a cytogenetically and molecularly confirmed 18q deletion was investigated by determining height, growth velocity, insulin-like growth factor I (IGF-I), IGF-binding protein-3, bone maturation, and response to pituitary stimulants of GH.

Children with 18q deletions are short; 64% have a height more than -2 SD below the mean. Affected children also grow slowly; 68% have a growth velocity more than -1 SD below the mean. Half of the individuals have delayed bone maturation. Growth factors are skewed downward; 72% of the IGF-I values and 83% of the IGF-binding protein-3 values are below the mean for chronological age. Similarly, 72% of the children had a reduced or absent response to either of the GH stimulants, arginine and clonidine. In the total group of 50 children only 2 were normal for all parameters evaluated.

Short stature and poor growth are common features of individuals with 18q deletions. GH deficiency is common in this cohort of patients and probably plays a role in the short stature seen in many of the affected individuals.

This article has been cited by other articles:

				R. L. Schaub, D. E. Hale, S. R. Rose, R. J. Leach, and J. D. Cody The Spectrum of Thyroid Abnormalities in Individuals with 18q Deletions J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2259 - 2263. [Abstract] [Full Text] [PDF]